FIGURE

Fig. 11

ID

ZDB-FIG-250821-29

Publication

Bentanachs et al., 2025 - Telmisartan Reverses Hepatic Steatosis via PCK1 Upregulation: A Novel PPAR-independent Mechanism in Experimental Models of MASLD

Other Figures

All Figure Page

Back to All Figure Page

Fig. 11

Evaluation of the effects of agtr1 or pck1 mutations, telmisartan treatment or both in OF+GL fed larvae. (A) Schematic representation of the experimental design. Scatter plot of the inversely normalized Liver Lipid Area and Liver Area individual values, along with margin plots for the untreated and treated controls as well as for their respective untreated and treated agtr1a/b (B) or pck1 (C) mutant siblings. Box plots showing the survival rate (%) in Telmisartan 2 µM treated or untreated experimental tanks from 8 to 10 days post fertilization. (D) Effect of mutations and telmisartan treatment or both on Length, Dorsal and Lateral area. Analysis was performed using multiple linear regression adjusting the values by “Time of day” and “Batch” (2 Batches). Fold change calculated using raw data is indicated when the differences are statistically significant (P < 0,05) between groups differing by a single variable.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Pharmacol. Res.